Table of Contents Author Guidelines Submit a Manuscript
Journal of Tropical Medicine
Volume 2011, Article ID 175941, 12 pages
http://dx.doi.org/10.1155/2011/175941
Review Article

Current Evidence on the Use of Antifilarial Agents in the Management of bancroftian Filariasis

1Department of Parasitology, Faculty of Medicine, University of Colombo, Colombo 08, Sri Lanka
2University Medical Unit, National Hospital of Sri Lanka, Colombo 08, Sri Lanka
3Department of Clinical Medicine, Faculty of Medicine, University of Colombo, Colombo 08, Sri Lanka

Received 25 September 2010; Accepted 29 November 2010

Academic Editor: Thomas R. Unnasch

Copyright © 2011 Sumadhya Deepika Fernando et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. WHO, “Lymphatic filariasis,” Geneva, Switzerland, June 2009, http://www.who.int/mediacentre/factsheets/fs102/en/.
  2. G. Chandra, “Nature limits filarial transmission,” Parasites and Vectors, vol. 1, no. 1, article 13, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. GAELF, “Clinical features,” June 2009, http://www.filariasis.org/all_about_lf/disease.html#clinicalfeatures.
  4. V. K. Vijayan, “Tropical pulmonary eosinophilia: pathogenesis, diagnosis and management,” Current Opinion in Pulmonary Medicine, vol. 13, no. 5, pp. 428–433, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. K. D. Ramaiah, H. Guyatt, K. Ramu, P. Vanamail, S. P. Pani, and P. K. Das, “Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south India,” Tropical Medicine and International Health, vol. 4, no. 1, pp. 19–25, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. K. D. Ramaiah, K. Ramu, H. Guyatt, K. N. Vijar Kumar, and S. P. Pani, “Direct and indirect costs of the acute form of lymphatic filariasis to households in rural areas of tamil nadu, south india,” Tropical Medicine and International Health, vol. 3, no. 2, pp. 108–115, 1998. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Johnson, C. D. Mackenzie, D. A. Denham, and R. R. Suswillo, “The effect of diethylcarbamazine on the in vitro serum-mediated adherence of feline granulocytes to microfilariae of Brugia pahangi,” Tropical Medicine and Parasitology, vol. 39, no. 4, pp. 291–294, 1988. View at Google Scholar · View at Scopus
  8. N. Kanesa-thasan, J. G. Douglas, and J. W. Kazura, “Diethylcarbamazine inhibits endothelial and microfilarial prostanoid metabolism in vitro,” Molecular and Biochemical Parasitology, vol. 49, no. 1, pp. 11–20, 1991. View at Publisher · View at Google Scholar · View at Scopus
  9. C. A. Peixoto, A. C. O. Santos, and C. F. J. Ayres, “Molecular evidence for apoptosis in microfilariae of Wuchereria bancrofti induced by diethylcarbamazine,” Parasitology Research, vol. 103, no. 3, pp. 717–721, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. E. A. Ottesen, “Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans,” Reviews of Infectious Diseases, vol. 7, no. 3, pp. 341–356, 1985. View at Google Scholar · View at Scopus
  11. M. Abramowicz, M. A. Rizack, D. Goodstein, A. Faucard, P. D. Hansten, and N. H. Steigbigel, “Drugs for parasitic infections,” Medical Letter on Drugs and Therapeutics, vol. 40, no. 1017, pp. 1–12, 1998. View at Google Scholar · View at Scopus
  12. D. Addiss and G. Dreyer, “Treatment of lymphatic filariasis,” in Lymphatic Filariasis, T. B. Nutman, Ed., pp. 103–125, Imperial College Press, London, UK, 2000. View at Google Scholar
  13. A. P. Oomen, “Fatalities after treatment of onchocerciasis with diethylcarbamazine,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 63, no. 4, p. 548, 1969. View at Google Scholar · View at Scopus
  14. A. C. Bird, H. El-Sheikh, J. Anderson, and H. Fuglsang, “Visual loss during oral diethylcarbamazine treatment for onchocerciasis,” Lancet, vol. 2, no. 8132, p. 46, 1979. View at Google Scholar · View at Scopus
  15. L. D. Andrade, Z. Medeiros, M. L. Pires et al., “Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 89, no. 3, pp. 319–321, 1995. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. R. Ramzy, M. El Setouhy, H. Helmy et al., “The impact of single-dose diethylcarbamazine treatment of bancroftian filariasis in a low-endemicity setting in Egypt,” American Journal of Tropical Medicine and Hygiene, vol. 67, no. 2, pp. 196–200, 2002. View at Google Scholar · View at Scopus
  17. M. V. Weerasooriya, E. Kimura, D. A. Dayaratna, T. R. Weerasooriya, and W. A. Samarawickrema, “Efficacy of a single dose treatment of Wuchereria bancrofti microfilaria carriers with diethylcarbamazine in Matara, Sri Lanka,” The Ceylon Medical Journal, vol. 43, no. 3, pp. 151–155, 1998. View at Google Scholar · View at Scopus
  18. M. K. Beuria, M. S. Bal, N. N. Mandal, and M. K. Das, “Antigenemia at 10 years after diethylcarbamazine treatment of asymptomatic microfilaraemic individuals: marginal conversion to infection-free state,” Parasite Immunology, vol. 24, no. 2, pp. 109–111, 2002. View at Publisher · View at Google Scholar · View at Scopus
  19. D. O. Freedman, D. Adam Plier, A. B. De Almeida, A. L. De Oliveira, J. Miranda, and C. Braga, “Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis,” Tropical Medicine and International Health, vol. 6, no. 1, pp. 37–41, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. S. P. Pani, G. Subramanyam Reddy, L. K. Das et al., “Tolerability and efficacy of single dose albendazole, diethylcarbamazine citrate (DEC) or co-administration of albendazole with DEC in the clearance of Wuchereria bancrofti in asymptomatic microfilaraemic volunteers in Pondicherry, South India: a hospital-based study,” Filaria Journal, vol. 1, no. 1, article 1, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. W. A. Stolk, G. J. Van Oortmarssen, S. P. Pani et al., “Effects of ivermectin and diethylcarbamazine on microfilariae and overall microfilaria production in bancroftian filariasis,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 5, pp. 881–887, 2005. View at Google Scholar · View at Scopus
  22. G. S. Reddy, N. Vengatesvarlou, P. K. Das et al., “Tolerability and efficacy of single-dose diethyl carbamazine (DEC) or ivermectin in the clearance of Wuchereria bancrofti microfilaraemia in Pondicherry, South India,” Tropical Medicine and International Health, vol. 5, no. 11, pp. 779–785, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Ducorps, N. Gardon-Wendel, S. Ranque et al., “Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectinEffets secondaires du traitement de la loase hypermicrofilarémique par l'ivermectine,” Bulletin de la Société de Pathologie Exotique, vol. 88, no. 3, pp. 105–112, 1995. View at Google Scholar · View at Scopus
  24. B. Carme, B. Ebikli, A. Mbitsi, and N. Copin, “Therapeutic trial with ivermectin against loiasis with medium and high microfilaremia,” Annales de la Societe Belge de Medecine Tropicale, vol. 71, no. 1, pp. 47–50, 1991. View at Google Scholar · View at Scopus
  25. G. Dreyer, D. Addiss, J. Williamson, and J. Norões, “Efficacy of co-administered diethylcarbamazine and albendazole against adult Wuchereria bancrofti,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 100, no. 12, pp. 1118–1125, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. M. J. Bockarie, L. Tavul, I. Ibam et al., “Efficacy of single-dose diethylcarbamazine compared with diethylcarbamazine combined with albendazole against Wuchereria bancrofti infection in Papua New Guinea,” American Journal of Tropical Medicine and Hygiene, vol. 76, no. 1, pp. 62–67, 2007. View at Google Scholar · View at Scopus
  27. L. M. Fox, B. W. Furness, J. K. Haser et al., “Tolerance and efficacy of combined diethylcarbamazine and albendazole for treatment of Wuchereria bancrofti and intestinal helminth infections in Haitian children,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 1, pp. 115–121, 2005. View at Google Scholar · View at Scopus
  28. O. Hussein, M. El Setouhy, E. S. Ahmed et al., “Duplex doppler sonographic assessment of the effects of diethylcarbamazine and albendazole therapy on adult filarial worms and adjacent host tissues in bancroftian filariasis,” American Journal of Tropical Medicine and Hygiene, vol. 71, no. 4, pp. 471–477, 2004. View at Google Scholar · View at Scopus
  29. M. El Setouhy, R. M. R. Ramzy, E. S. Ahmed et al., “A randomized clinical trial comparing single- and multi-dose combination therapy with diethylcarbamazine and albendazole for treatment of bancroftian filariasis,” American Journal of Tropical Medicine and Hygiene, vol. 70, no. 2, pp. 191–196, 2004. View at Google Scholar · View at Scopus
  30. M. J. Beach, T. G. Streit, D. G. Addiss, R. Prospere, J. M. Roberts, and P. J. Lammie, “Assessment of combined ivermectin and albendazole for treatment of intestinal helminth and Wuchereria bancrofti infections in Haitian schoolchildren,” American Journal of Tropical Medicine and Hygiene, vol. 60, no. 3, pp. 479–486, 1999. View at Google Scholar · View at Scopus
  31. F. O. Richards, D. D. Pam, A. Kal et al., “Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria,” Annals of Tropical Medicine and Parasitology, vol. 99, no. 2, pp. 155–164, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  32. W. A. Stolk, S. J. De Vlas, and J. D. F. Habbema, “Anti-Wolbachia treatment for lymphatic filariasis,” Lancet, vol. 365, no. 9477, pp. 2067–2068, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  33. M. M. Ismail, R. L. Jayakody, G. J. Weil et al., “Long-term efficacy of single-dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 95, no. 3, pp. 332–335, 2001. View at Google Scholar · View at Scopus
  34. M. M. Ismail, R. L. Jayakody, G. J. Weil et al., “Efficacy of single dose combinations of albendazole, ivermectin and diethylcarbamazine for the treatment of bancroftian filariasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 92, no. 1, pp. 94–97, 1998. View at Publisher · View at Google Scholar · View at Scopus
  35. S. K. Dunyo, F. K. Nkrumah, and P. E. Simonsen, “Single-dose treatment of Wuchereria bancrofti infections with ivermectin and albendazole alone or in combination: evaluation of the potential for control at 12 months after treatment,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 4, pp. 437–443, 2000. View at Google Scholar · View at Scopus
  36. S. K. Dunyo, F. K. Nkrumah, and P. E. Simonsen, “A randomized double-blind placebo-controlled field trial of ivermectin and albendazole alone and in combination for the treatment of lymphatic filariasis in Ghana,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 94, no. 2, pp. 205–211, 2000. View at Google Scholar · View at Scopus
  37. W. H. Makunde, L. M. Kamugisha, J. J. Massaga et al., “Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis,” Filaria Journal, vol. 2, no. 1, article 15, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  38. M. E. A. De Kraker, W. A. Stolk, G. J. Van Oortmarssen, and J. D. F. Habbema, “Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti,” Tropical Medicine and International Health, vol. 11, no. 5, pp. 718–728, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  39. M. J. Bockarie, D. J. Tisch, W. Kastens et al., “Mass treatment to eliminate filariasis in Papua New Guinea,” New England Journal of Medicine, vol. 347, no. 23, pp. 1841–1848, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  40. M. J. Bockarie, E. Ibam, N. D. E. Alexander et al., “Towards eliminating lymphatic filariasis in Papua New Guinea: impact of annual single-dose mass treatmnet on transmission of Wuchereria bancrofti in East Sepik Province,” Papua and New Guinea Medical Journal, vol. 43, no. 3-4, pp. 172–182, 2000. View at Google Scholar · View at Scopus
  41. D. J. Tisch, M. J. Bockarie, Z. Dimber et al., “Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation,” American Journal of Tropical Medicine and Hygiene, vol. 78, no. 2, pp. 289–293, 2008. View at Google Scholar · View at Scopus
  42. M. M. Ismail, G. J. Weil, K. S. A. Jayasinghe et al., “Prolonged clearance of microfilaraemia in patients with bancroftian filariasis after multiple high doses of ivermectin or diethylcarbamazine,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 6, pp. 684–688, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. GAELF, “Progress to date,” June 2009, http://www.filariasis.org/all_about_lf/disease.html#clinicalfeatures.
  44. D. Kyelem, S. Sanou, B. Boatin, J. Medlock, S. Coulibaly, and D. H. Molyneux, “Impact of long-term ivermectin (Mectizan) on Wuchereria bancrofti and Mansonella perstans infections in Burkina Faso: strategic and policy implications,” Annals of Tropical Medicine and Parasitology, vol. 97, no. 8, pp. 827–838, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  45. F. O. Richards, A. Eigege, D. Pam et al., “Mass ivermectin treatment for onchocerciasis: lack of evidence for collateral impact on transmission of Wuchereria bancrofti in areas of co-endemicity,” Filaria Journal, vol. 4, article 6, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. K. D. Ramaiah, P. K. Das, P. Vanamail, and S. P. Pani, “Impact of 10 years of diethylcarbamazine and ivermectin mass administration on infection and transmission of lymphatic filariasis,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 101, no. 6, pp. 555–563, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. J. L. Liang, J. D. King, K. Ichimori, T. Handzel, M. Pa'au, and P. J. Lammie, “Impact of five annual rounds of mass drug administration with diethylcarbamazine and albendazole on Wuchereria bancrofti infection in American Samoa,” American Journal of Tropical Medicine and Hygiene, vol. 78, no. 6, pp. 924–928, 2008. View at Google Scholar · View at Scopus
  48. J. U. Mataika, E. Kimura, J. Koroivueta, and M. Shimada, “Efficacy of five annual single doses of diethylcarbamazine for treatment of lymphatic filariasis in Fiji,” Bulletin of the World Health Organization, vol. 76, no. 6, pp. 575–579, 1998. View at Google Scholar · View at Scopus
  49. P. C. Fan, “Eradication of bancroftian filariasis by diethylcarbamazine-medicated common salt on Little Kinmen (Liehyu District), Kinmen (Quemoy) Islands, Republic of China,” Annals of Tropical Medicine and Parasitology, vol. 84, no. 1, pp. 25–33, 1990. View at Google Scholar · View at Scopus
  50. P. C. Fan, H. W. Peng, and C. C. Chen, “Follow-up investigations on clinical manifestations after filariasis eradication by diethylcarbamazine medicated common salt on Kinmen (Quemoy) Islands, Republic of China,” Journal of Tropical Medicine and Hygiene, vol. 98, no. 6, pp. 461–464, 1995. View at Google Scholar · View at Scopus
  51. D. W. Meyrowitsch, P. E. Simonsen, and W. H. Makunde, “Mass diethylcarbamazine chemotherapy for control of bancroftian filariasis through community participation: comparative efficacy of a low monthly dose and medicated salt,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 1, pp. 74–79, 1996. View at Publisher · View at Google Scholar · View at Scopus
  52. P. Krishnarao, R. Kaur, and T. K. Ghosh, “Long term effect of diethylcarbamazine medicated common salt on bancroftian filariasis,” Journal of Communicable Diseases, vol. 23, no. 2, pp. 128–130, 1991. View at Google Scholar · View at Scopus
  53. S. Adinarayanan, J. Critchley, P. K. Das, and H. Gelband, “Diethylcarbamazine (DEC)-medicated salt for community-based control of lymphatic filariasis,” Cochrane Database of Systematic Reviews, vol. 24, no. 1, Article ID CD003758, 2007. View at Google Scholar · View at Scopus
  54. D. W. Meyrowitsch, P. E. Simonsen, and W. H. Makunde, “Mass DEC chemotherapy for control of bancroftian filariasis: comparative efficacy of four strategies two years after start of treatment,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 90, no. 4, pp. 423–428, 1996. View at Publisher · View at Google Scholar · View at Scopus
  55. L. Jingyuan, C. Zi, H. Xiaohang, and T. Zhaoping, “Mass treatment of filariasis using DEC-medicated salt,” Journal of Tropical Medicine and Hygiene, vol. 95, no. 2, pp. 132–135, 1992. View at Google Scholar · View at Scopus
  56. M. V. Narasimham, S. P. Sharma, R. M. Sundaram et al., “Control of bancroftian filariasis by diethylcarbamazine medicated common salt in Karaikal, Pondicherry, India,” Journal of Communicable Diseases, vol. 21, no. 3, pp. 157–170, 1989. View at Google Scholar · View at Scopus
  57. A. R. Freeman, P. J. Lammie, R. Houston et al., “A community-based trial for the control of lymphatic filariasis and iodine deficiency using salt fortified with diethylcarbamazine and iodine,” American Journal of Tropical Medicine and Hygiene, vol. 65, no. 6, pp. 865–871, 2001. View at Google Scholar · View at Scopus
  58. D. W. Meyrowitsch, P. E. Simonsen, and S. M. Magesa, “Long-term effect of three different strategies for mass diethylcarbamazine administration in bancroftian filariasis: follow-up at 10 years after treatment,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 98, no. 11, pp. 627–634, 2004. View at Google Scholar
  59. I. P. Sunish, R. Rajendran, T. R. Mani, A. Munirathinam, A. P. Dashb, and B. K. Tyagi, “Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India,” Bulletin of the World Health Organization, vol. 85, no. 2, pp. 138–145, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. I. P. Sunish, R. Rajendran, T. R. Mani et al., “Resurgence in filarial transmission after withdrawal of mass drug administration and the relationship between antigenaemia and microfilaraemia—a longitudinal study,” Tropical Medicine and International Health, vol. 7, no. 1, pp. 59–69, 2002. View at Publisher · View at Google Scholar
  61. P. E. Simonsen, D. W. Meyrowitsch, D. A. Mukoko et al., “The effect of repeated half-yearly diethylcarbamazine mass treatment on Wuchereria bancrofti infection and transmission in two East African communities with different levels of endemicity,” American Journal of Tropical Medicine and Hygiene, vol. 70, no. 1, pp. 63–71, 2004. View at Google Scholar · View at Scopus
  62. P. Esterre, C. Plichart, Y. Sechan, and N. L. Nguyen, “The impact of 34 years of massive DEC chemotherapy on Wuchereria bancrofti infection and transmission: the Maupiti cohort,” Tropical Medicine and International Health, vol. 6, no. 3, pp. 190–195, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. E. Michael, M. N. Malecela, M. Zervos, and J. W. Kazura, “Global eradication of lymphatic filariasis: the value of chronic disease control in parasite elimination programmes,” PLoS ONE, vol. 3, no. 8, Article ID e2936, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. E. Michael, M. N. Malecela-Lazaro, and J. W. Kazura, “Epidemiological modelling for monitoring and evaluation of lymphatic filariasis control,” Advances in Parasitology, vol. 65, pp. 191–237, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. K. Awadzi, D. A. Boakye, G. Edwards et al., “An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana,” Annals of Tropical Medicine and Parasitology, vol. 98, no. 3, pp. 231–249, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. R. K. Prichard, “Markers for benzimidazole resistance in human parasitic nematodes?” Parasitology, vol. 134, no. 8, pp. 1087–1092, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. A. E. Schwab, D. A. Boakye, D. Kyelem, and R. K. Prichard, “Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment,” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 234–238, 2005. View at Google Scholar · View at Scopus
  68. A. E. Schwab, T. S. Churcher, A. J. Schwab, M. G. Basáñez, and R. K. Prichard, “An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy,” Parasitology, vol. 134, no. 7, pp. 1025–1040, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. J. Mccarthy, “Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis?” American Journal of Tropical Medicine and Hygiene, vol. 73, no. 2, pp. 232–233, 2005. View at Google Scholar · View at Scopus
  70. A. Hoerauf, “Filariasis: new drugs and new opportunities for lymphatic filariasis and onchocerciasis,” Current Opinion in Infectious Diseases, vol. 21, no. 6, pp. 673–681, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. A. Hoerauf, S. Mand, K. Fischer et al., “Doxycycline as a novel strategy against bancroftian filariasis - Depletion of Wolbachia endosymbionts from Wuchereria bancrofti and stop of microfilaria production,” Medical Microbiology and Immunology, vol. 192, no. 4, pp. 211–216, 2003. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. M. J. Taylor, W. H. Makunde, H. F. McGarry, J. D. Turner, S. Mand, and A. Hoerauf, “Macrofilaricidal activity after doxycycline treatment of Wuchereria bancrofti: a double-blind, randomised placebo-controlled trial,” Lancet, vol. 365, no. 9477, pp. 2116–2121, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. A. Y. Debrah, S. Mand, Y. Marfo-Debrekyei et al., “Macrofilaricidal effect of 4 weeks of treatment with doxycycline on Wuchereria bancrofti,” Tropical Medicine and International Health, vol. 12, no. 12, pp. 1433–1441, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. A. Y. Debrah, S. Mand, Y. Marfo-Debrekyei et al., “Reduction in levels of plasma vascular endothelial growth factor-A and improvement in hydrocele patients by targeting endosymbiotic Wolbachia sp. in Wuchereria bancrofti with doxycycline,” American Journal of Tropical Medicine and Hygiene, vol. 80, no. 6, pp. 956–963, 2009. View at Google Scholar · View at Scopus
  75. J. D. Turner, S. Mand, A. Y. Debrah et al., “A randomized, double-blind clinical trial of a 3-week course of doxycycline plus albendazole and ivermectin for the treatment of Wuchereria bancrofti infection,” Clinical Infectious Diseases, vol. 42, no. 8, pp. 1081–1089, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. A. Y. Debrah, S. Mand, S. Specht et al., “Doxycycline reduces plasma VEGF-C/sVEGFR-3 and improves pathology in lymphatic filariasis.,” PLoS Pathogens, vol. 2, no. 9, article e92, 2006. View at Google Scholar · View at Scopus
  77. M. V. Weerasooriya, N. K. Gunawardena, M. Itoh, X. G. Qiu, and E. Kimura, “Prevalence and intensity of Wuchereria bancrofti antigenaemia in Sri Lanka by Og4C3 ELISA using filter paper-absorbed whole blood,” Transactions of the Royal Society of Tropical Medicine and Hygiene, vol. 96, no. 1, pp. 41–45, 2002. View at Publisher · View at Google Scholar · View at Scopus